Dianthus Therapeutics, Inc. - Enterprise Value

The Enterprise Value as of July 2026 (TTM) for Dianthus Therapeutics, Inc. (DNTH) is 3.72B

According to Dianthus Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.72B. This represents a change of 112.53% compared to the average of 1.75B of the last 4 quarters.

Dianthus Therapeutics, Inc. (DNTH) Historical Enterprise Value (quarterly & annually)

How has DNTH Enterprise Value performed in the past?

The mean historical Enterprise Value of Dianthus Therapeutics, Inc. over the last ten years is 414.03M. The current 3.72B Enterprise Value has changed 89.74% with respect to the historical average. Over the past ten years (40 quarters), DNTH's Enterprise Value was at its highest in in the March 2026 quarter at 3.40B. The Enterprise Value was at its lowest in in the September 2023 quarter at -103204868.38.

Dianthus Therapeutics, Inc. (DNTH) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Dianthus Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Dianthus Therapeutics, Inc. (DNTH) Average Enterprise Value

How has DNTH Enterprise Value performed in the past?

The current Enterprise Value of Dianthus Therapeutics, Inc. (DNTH) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Dianthus Therapeutics, Inc. (DNTH) Enterprise Value vs. Peers

How is DNTH’s Enterprise Value compared to its peers?

Dianthus Therapeutics, Inc.’s Enterprise Value is greater than Enliven Therapeutics, Inc. (3.65B), greater than Taysha Gene Therapies, Inc. (1.54B), greater than Sana Biotechnology, Inc. (873.71M), greater than Atai Beckley Inc. (2.62B), greater than Nektar Therapeutics (1.39B), greater than AnaptysBio, Inc. (2.28B), greater than Oculis Holding AG (443.05M), greater than BridgeBio Oncology Therapeutics Inc. (609.67M), greater than Immatics N.V. (765.88M), greater than Tourmaline Bio, Inc. (1.20B),

Build a custom stock screener for Dianthus Therapeutics, Inc. (DNTH) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Dianthus Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Dianthus Therapeutics, Inc. (DNTH) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Dianthus Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.